- Cantourage introduces second Clever Leaves medical cannabis
product to the German market
- IQANNA No 10, a high-THC dried flower product based on the
Wappa cultivar, produced at Clever Leaves' Portugal facility, is available in German
pharmacies
- Caroline Kliess, Managing Director of Clever Leaves Germany,
comments: "We are excited to intensify our partnership with
Cantourage and launch our next medical cannabis flower product
under the IQANNA brand"
BERLIN, June 8, 2022
/PRNewswire/ -- European medical cannabis leader Cantourage GmbH
("Cantourage") and Clever Leaves Holdings Inc. (NASDAQ: CLVR,
CLVRW) ("Clever Leaves") a leading multinational operator and
licensed producer of pharmaceutical-grade cannabinoids, have
continued to intensify their strategic partnership for the
distribution of medical cannabis flowers throughout Germany.
Following the successful introduction of Clever Leaves' IQANNA
No 7 medical cannabis flowers to the German pharmaceutical market,
Cantourage and Clever Leaves launched the 'IQANNA No 10'-branded
Wappa cultivar. The dried flower product is cultivated in Clever
Leaves' facility in Portugal,
where the company operates approximately 25,000 m2 of actively producing
GACP-certified greenhouses.
Cantourage processes the Wappa-based IQANNA No 10 cannabis
flowers, transforming them to medical cannabis products with one of
the highest THC levels available in German pharmacies. Cantourage's
and Clever Leaves' expanded partnership further increases the range
of international, high-quality medical cannabis products that
Cantourage has been making available to the EU market.
Cantourage manufactures and distributes medical cannabis
products sourced from around the world and makes them available to
patients in Germany and
Europe. IQANNA No 10 is the second
Clever Leaves product made available to patients in Germany, with further products under the
IQANNA brand to be introduced in Germany in the coming weeks.
Philip Schetter, CEO of
Cantourage, commented: "Today's launch of the IQANNA No 10 medical
cannabis flowers is an important step in our intensified
partnership with Clever Leaves and further improves the already
growing range of medical cannabis products available to German
pharmacies and patients. Clever Leaves is a large-scale and
experienced multinational operator with sustainable operations and
excellent quality products from countries with exceptional natural
growing conditions. We very much look forward to further deepening
our partnership and making further Clever Leaves products available
to German patients, among whom we know that demand levels are very
high".
Caroline Kliess, Managing Director of Clever Leaves Germany
GmbH, added: "We are excited to extend our partnership with
Cantourage and launch our next medical cannabis flower product
under the IQANNA brand.
Andres Fajardo, CEO of Clever
Leaves, stated: "Broadening distribution is an important goal, and
we are delighted that the successful strategic partnership with
Cantourage has allowed us to take this next step in bringing our
high-quality products and brands into the European market. We are
excited about the opportunity to play a role in meeting the needs
of the quickly growing key markets of Germany and Europe".
About Cantourage GmbH
Cantourage GmbH is a leading European medical cannabis company.
The Berlin-based company was
founded in 2019 by industry pioneers Dr Florian Holzapfel, Norman Ruchholtz and
Patrick Hoffmann.
With its unique Fast Track Access platform, Cantourage enables
producers from across the world to become part of the rapidly
growing European medical cannabis market. Cantourage focuses on
long-term collaborations and strategic partnerships: each partner
along the value chain can focus on what they do best – from growers
to logistics, manufacturers to pharmacies and wholesalers. All with
one clear goal in mind: to provide patients in Europe with an unprecedented selection of the
highest quality cannabis medicines at affordable prices. Cantourage
offers products in all relevant market segments: dried flowers,
extracts, Dronabinol and pharma-grade Cannabidiol.
About Clever Leaves Holdings Inc.
Clever Leaves is a leading multinational operator and licensed
producer of pharmaceutical-grade cannabinoids. Its operations in
Colombia and Portugal produce cannabinoid active
pharmaceutical ingredients (API) and finished products in flower
and extract form to a growing base of B2B customers around the
globe. Clever Leaves aims to disrupt the traditional cannabis
production industry by leveraging environmentally sustainable,
ESG-friendly, industrial-scale and low-cost production methods,
with the world's most stringent pharmaceutical quality
certifications. For more information, please
visit https://cleverleaves.com/en/home/ and follow Clever
Leaves on Twitter and LinkedIn.
Photo -
https://mma.prnewswire.com/media/1835367/Cantourage.jpg
Logo
- https://mma.prnewswire.com/media/1835368/Cantourage_Clever_Leaves_logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cantourage-and-clever-leaves-intensify-strategic-partnership-for-distribution-of-medical-cannabis-in-germany-301563889.html
SOURCE Cantourage